未登录

P

Paweł Surowiak

Berlin Institute of Health

H指数:34

被引数:4,715

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A case-control study on the effect of rhythmic masticatory muscle activity (RMMA) clusters on sleep fragmentation and severity of orofacial muscle pain in sleep bruxism

JOURNAL OF SLEEP RESEARCH

IF3.9

2023-10-2011

PRE

The photodynamic effect of far-red range phthalocyanines (AIPc and Pc green) supported by electropermeabilization in human gastric adenocarcinoma cells of sensitive and resistant type

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2015-02-0118

PREAI

Doxorubicin delivery enhanced by electroporation to gastrointestinal adenocarcinoma cells with P-gp overexpression

BIOELECTROCHEMISTRY

IF4.5

2014-12-0132

PREAI

Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph node-negative early breast cancer: 15-year follow-up

ONCOLOGY REPORTS

IF3.9

2014-02-1826

OAAI

YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2013-09-1847

OAAI

ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up

乳腺导管癌ERM/Rho蛋白表达: 15年随访

CELLULAR ONCOLOGY

IF4.8

2013-02-1931

OAAI

PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer

BRITISH JOURNAL OF CANCER

IF6.8

2009-12-1545

OAAI

Positive correlation between cyclooxygenase-2 and ABC-transporter expression in non-Hodgkin's lymphomas

ONCOLOGY REPORTS

IF3.9

2009-10-1420

OAAI

Betulinic acid exhibits stronger cytotoxic activity on the normal melanocyte NHEM-neo cell line than on drug-resistant and drug-sensitive MeWo melanoma cell lines

MOLECULAR MEDICINE REPORTS

IF3.5

2009-06-0410

OAAI

Comparision of the Cytotoxic Effects of Birch Bark Extract, Betulin and Betulinic Acid Towards Human Gastric Carcinoma and Pancreatic Carcinoma Drug-sensitive and Drug-Resistant Cell Lines

白桦树皮提取物、桦木醇、桦木酸对人胃癌和胰腺癌耐药细胞株细胞毒作用的比较

IF4.6

2009-04-2466

OAAI

Unfavourable prognostic significance of S100P expression in ovarian cancers

IF4.1

2007-05-3134

PREAI

Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome

VIRCHOWS ARCHIV

IF3.1

2007-01-1982

PRE

Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients

VIRCHOWS ARCHIV

IF3.1

2007-01-1020

PRE

ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome

CLINICAL CANCER RESEARCH

IF10.2

2006-12-0496

OAAI

Synthesis and the biological activity of the phosphonic inhibitors of urokinase type plasminogen activator

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2006-10-010

PREAI

Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers

BRITISH JOURNAL OF CANCER

IF6.8

2006-08-0555

OAAI

Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus:: Implications for combinatorial treatment regimen with chemotherapeutic agents

CANCER RESEARCH

IF16.6

2006-07-1850

PREAI

Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancers

IF10.1

2006-04-0144

PRE

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2005-10-10148

OAAI

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

BREAST CANCER RESEARCH

IF5.6

2005-08-2574

OAAI